Koya Medical launches Dayspring lower extremity active compression treatment for lymphedema and venous disorders. CMS issues three new billing codes.
Koya Medical Launches Lower Extremity Compression Treatment Read More »
Podimetrics, a leader in complex diabetes care solutions, has joined forces with Alivi Health to integrate its innovative SmartMat™ technology into Alivi’s podiatry benefits portfolio.
Podimetrics and Alivi Health Announce New Partnership to Support Diabetic Foot Health Read More »
Discover how Podimetrics reduces amputation risks in diabetes care, as featured on WCVB’s *Chronicle*. Learn about their innovative approach and patient success stories.
Podimetrics Featured on WCVB Chronicle, Highlighting Innovative Diabetes Care Read More »
At AMCP, Koya Medical showcased the NILE Trial results: Dayspring device outperformed APCD in treating lymphedema, providing greater adherence and satisfaction.
Koya Medical Selected for Presentation at AMCP Conference Read More »
Provider status with Medi-Cal will allow Mindera Health to provide its proprietary Mind.Px test to predict biologic class response in plaque psoriasis to the over 15 million Medi-Cal Beneficiaries. San Diego, CA, Aug 19, 2024 (GLOBE NEWSWIRE) — Mindera Health, developer of Mind.Px™, the first realization of precision medicine in psoriasis, has completed the credentialling
Mindera Health™ becomes a Medi-Cal™ Credentialled Provider Read More »
Lucas is an Industry veteran who brings expertise in commercialization, operations, business development, and finance to Procyrion as it continues to focus on its DRAIN-HF pivotal IDE trial and begins preparation for US commercialization of its Aortix percutaneous mechanical circulatory support (pMCS) technology.
Procyrion Announces Appointment of Lucas Buchanan to Board of Directors Read More »
Eirion to Present Update on Its Neuromodulator Product Candidates at The Medical Aesthetic Injectable Summit 2024October 1, 2024 – Woburn, MA – Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced today that successful results had been achieved in its Phase 1 – 2 clinical trial for the treatment of
Koya Medical announces positive interim results from randomized controlled study of Dayspring active compression treatment for lymphedema and venous disease.
Positive Interim Results for Dayspring Lymphedema Treatment Read More »
Koya Medical presented two clinical studies at AVLS showcasing improvements in lymphedema and venous disease outcomes with Dayspring active compression.
Koya Medical Presents Clinical Studies on Dayspring at AVLS Read More »